• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Deciphera Pharmaceuticals, Inc. - Common Stock (NQ:DCPH)

25.59 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 25.59
Bid (Size) 25.58 (120)
Ask (Size) 25.60 (2)
Prev. Close 25.59
Today's Range 25.59 - 25.59
52wk Range N/A - N/A
Shares Outstanding 58,041,410
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)
June 18, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet
June 03, 2024
From Deciphera Pharmaceuticals, Inc.
Via Business Wire

Performance

More News

Read More
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)
May 30, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings) ↗
April 30, 2024
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)
May 20, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace, Inc. (NYSE – SQSP), PlayAGS, Incorporated (NYSE – AGS), HashiCorp Inc. (Nasdaq – HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq – DCPH)
May 13, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 ↗
May 10, 2024
Via InvestorPlace
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS, Incorporated (NYSE - AGS), HashiCorp Inc. (Nasdaq - HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq - TBNK)
May 09, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH
May 01, 2024
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp Inc. (Nasdaq - HCP), Heartland Financial, USA Inc. (Nasdaq - HTLF), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq -
April 29, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views ↗
April 29, 2024
Via Benzinga
Topics Stocks
News headline image
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
April 29, 2024
Via Benzinga
News headline image
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday? ↗
April 29, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
April 29, 2024
Via Benzinga
News headline image
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday? ↗
April 29, 2024
Via Benzinga
News headline image
Crude Oil Down Over 1%; Deciphera Pharmaceuticals Shares Spike Higher ↗
April 29, 2024
Via Benzinga
News headline image
Why Is Mullen Automotive (MULN) Stock Up 27% Today? ↗
April 29, 2024
Via InvestorPlace
News headline image
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗
April 29, 2024
Via Benzinga
News headline image
Citi Just Raised Its Price Target on Shopify (SHOP) Stock ↗
April 29, 2024
Via InvestorPlace
News headline image
Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today? ↗
April 29, 2024
Via InvestorPlace
News headline image
Dow Surges Over 100 Points; Domino's Pizza Posts Upbeat Earnings ↗
April 29, 2024
Via Benzinga
Topics Stocks
News headline image
Deciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 Billion ↗
April 29, 2024
Via Investor's Business Daily
News headline image
DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders
April 29, 2024
From Halper Sadeh LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
April 29, 2024
Via Benzinga
News headline image
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
April 29, 2024
From Deciphera Pharmaceuticals, Inc.
Via Business Wire

Frequently Asked Questions

Is Deciphera Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Deciphera Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Deciphera Pharmaceuticals, Inc. - Common Stock trade on?
Deciphera Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Deciphera Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Deciphera Pharmaceuticals, Inc. - Common Stock is DCPH on the Nasdaq Stock Market
What is the current price of Deciphera Pharmaceuticals, Inc. - Common Stock?
The current price of Deciphera Pharmaceuticals, Inc. - Common Stock is 25.59
When was Deciphera Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Deciphera Pharmaceuticals, Inc. - Common Stock was at 06/10/24 04:00 PM ET
What is the market capitalization of Deciphera Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Deciphera Pharmaceuticals, Inc. - Common Stock is 1.49B
How many shares of Deciphera Pharmaceuticals, Inc. - Common Stock are outstanding?
Deciphera Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap